A position statement on therapeutic carbohydrate reduction nutrition interventions for people with type 1 diabetes has been published by the Society of Metabolic Health Practitioners.

The results of the first National Diabetes Experience Survey are now available online.

Spirit Health has announced its new continuous glucose monitor (CGM), CareSens Air, will be available on the Drug Tariff from 1st February this year.

Different methods to navigate the complexities of autism and neurodiversity among people with type 1 diabetes have been published in the latest book of a renowned researcher.   

Healthcare professionals across Leicestershire are being offered a unique opportunity to enhance their careers and drive sustainability through North Warwickshire and South Leicestershire College’s (NWSLC) new Skills Bootcamp.

The share of people with type 1 diabetes who are prescribed a GLP-1 receptor agonist or SGLT2 inhibitor rose from 0.7 per cent to 8.3 per cent between 2010 and 2023, evidence has shown.

A new eLearning course to improve the treatment and management of early onset type 2 diabetes has been launched by Effective Diabetes Education Now (EDEN). 

Patients with diabetic foot ulcer infection with lower C-reactive protein (CRP) values are at lower risk of adverse outcomes, according to research which set out to examine whether CRP could be used to determine the best point of discharge for hospital patients admitted with infected DFUs.

Recent research has shown that canagliflozin was linked to a 2.1 per cent increase in total iron-binding capacity and improved haemoglobin levels for people with chronic kidney disease and type 2 diabetes.

A short training topic on managing diabetes in the emergency department has been launched by the Cambridge Diabetes Education Programme (CDEP).

A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type 2 diabetes, liver disease and heart disease.

Those with experience of managing diabetic foot ulcer have been invited to take part in a survey aiming to collect the most important baseline patient characteristics which should be reported by studies assessing interventions for diabetic foot ulcers.

The latest EDFN webinar will share guidance and further insights into diabetes footcare in dark skin tones, in light of a new handbook from Diabetes Africa.

New research has highlighted a “significant association” between low Toe Brachial Index (TBI) and the presence of coronary artery disease (CAD) in diabetic foot syndrome patients, suggesting TBI could be a valuable screening tool for identifying CAD within this population.

A new drug delivery system can cut the dosing schedule for semaglutide to just once a month, according to new research presented at EASD 2024.

The results from clinical trials evaluating once weekly insulin efsitora alfa in adults with type 2 diabetes using basal insulin for the first time have been released.

Researchers have published the first study to document the sausage toe as a prevalent presentation of diabetic toe infection.

Adults with obesity or overweight and prediabetes had a 94 per cent lower risk of progressing to type 2 diabetes after taking tirzepatide, drugmaker Eli Lilly and Co. reported.

Nine “significant” risk factors for lower extremity amputation in diabetic foot ulcer patients have been identified in new research.